## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---
last_verified: "2026-05-18T20:40:42.172Z"
---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Elescan"
developer_entity: "Anescribe, LLC"
bundle_id: "com.elescan.Elescan"
app_store_id: "6743489325"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Freemium"
offline_capable: false
market_region: "US"
platforms: "iOS"
app_last_updated: "2026-01-28"
report_date: "2026-05-18"
last_verified: "2026-05-18"
report_version: "1.16"
total_reviews: 5
overall_rating: 4.2
sentiment: "Thrilled"
sentiment_score: 90
confidence: "low"
confidence_score: 0.55
top_praise_theme: "Healthcare professionals value the simple setup process for managing sensitive patient information"
review_sample_size: 2
total_review_count: 2
analyzed_review_count: 2
data_age_days: 0
momentum_velocity: "maintenance"
intelligence_version: 5
competitor_count: 5
tags: ["medical", "freemium", "thrilled sentiment", "mobile app", "app review", "app analysis", "healthcare", "providers", "medical"]
canonical_url: "https://marlvel.ai/intel-report/medical/elescan"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

# Elescan App Audit

## TL;DR {#tldr}

- **Category**: Medical · Freemium
- **Signal**: Rating 4.2 · Sentiment Thrilled
- **Recent focus**: Healthcare professionals value the simple setup process for managing sensitive patient information (top praise)

> **TL;DR:** Elescan is a medical app by Anescribe, LLC, rated 4.2/5 by 5 users, with Thrilled user sentiment (90/100), available on iOS.
>
> **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Elescan maintains Thrilled user sentiment (4.2/5 from 5 reviews), with users consistently praising healthcare professionals value the simple setup process for managing sensitive patient information.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 4.2/5 (5 reviews) |
| **User Mood** | Thrilled |
| **Category** | Medical |
| **Developer** | Anescribe, LLC |
| **Pricing** | Freemium |
| **Platforms** | iOS |
| **Confidence** | Low (0.55/1.0) |
| **Data Age** | 0d |

## Metadata & Market Performance
- **Publisher:** Anescribe, LLC
- **Category:** Medical
- **Target Audience:** Healthcare providers and medical billers who need to digitize, store, and share patient documentation while maintaining HIPAA compliance.
- **Platforms:** iOS
- **Version Audited:** 1.16
- **Audit Date:** 2026-05-18
- **Signal Count:** 2 reviews analyzed
- **Confidence:** Low (0.55/1.0)
- **App Store ID (iOS):** 6743489325
- **Bundle ID:** com.elescan.Elescan
- **Performance Trend:** Mixed
- **Data Window:** Analysis based on signals collected up to 2026-05-18

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** Elescan is a HIPAA-compliant document scanning and cloud storage app for healthcare providers on iOS.
**Why users hire it:** Providers hire Elescan to digitize patient records securely without the technical overhead of encrypted email, serving the job of compliant, low-friction document transfer.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] HIPAA-Compliant Cloud Storage:** Automatic secure backup of scanned documents to a HIPAA-compliant cloud environment
  * *User Intent:* Users expect seamless access across multiple devices.
- **[Differentiator] Secure Document Sharing:** Generation of access links for documents to replace email attachments
  * *User Intent:* Users prioritize data protection and trust in the platform.
- **[Differentiator] QR Code Login:** Authentication for desktop web console via mobile app QR scan
  * *User Intent:* Users are motivated by consistent progression and daily incentives.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

Elescan occupies a specialized medical utility niche, holding a 4.2-star rating across its initial user base. The focus on HIPAA-compliant storage differentiates it from general-purpose scanners, though the $11.00 monthly price point requires high-frequency professional usage to justify the cost.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Freemium
- **Tiers:** Free tier with limited scans, Pro Monthly at $11.00/month, Pro Yearly at $109.99/year
- **Analysis:** Freemium model anchored at $11.00/month, utilizing unlimited storage and sharing as the primary conversion lever.

<!-- section:sentiment -->
## 🟢 User Sentiment (Low Confidence: 2 of 2 reviews analyzed) {#user-sentiment}
- **Overall Rating:** 4.2/5
- **Platform Split:** iOS 4.2/5 (5 ratings)
- **Overall Sentiment:** Thrilled

### Top Praises
- **Healthcare professionals value the simple setup process for managing sensitive patient information**
- **HIPAA compliance integration provides necessary security for handling medical data without complex workarounds**

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Physician-owned trust signal in clinical settings
- HIPAA-compliant BAA-backed document workflow

**Critical Frictions:**
- $11.00/month subscription exceeds generic scanner pricing
- Limited to mobile-first capture workflows

**Growth Levers:**
- Integration with existing EHR platforms
- B2B partnerships with medical billing firms

**Market Threats:**
- Established EHR suites adding mobile-capture features
- Tightening data-privacy regulations increasing compliance costs

<!-- /section:swot -->
## Recent Changes (v4 → v5) {#recent-changes}

The intelligence report reflects a strategic pivot from commercial conversion tactics to product-level integration with EHR systems to address long-term churn risks.

**Overall trend**: Mixed
**Compared at**: 2026-05-18

### High-impact changes
- **[Shifted] Strategic Focus Pivot** (positioning) — Shifted from prioritizing pricing-barrier reduction (free trials/Lite tiers) to prioritizing EHR platform integration to ensure long-term clinical utility.

### Medium-impact changes
- **[Added] New SWOT Items** (swot) — Added 'Tightening data-privacy regulations' as a threat and 'B2B partnerships with medical billing firms' as an opportunity.
- **[Shifted] Target Audience Refinement** (audience) — Expanded target audience definition to explicitly include medical billers alongside healthcare providers.

<!-- section:whats-new -->
## What's New

- **Latest (v1.16, 3 months ago):** Fixed cloud storage upload failures for files with special characters and improved naming validation.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Maintenance) {#momentum}

- Improved file naming validation logic.
- Fixed upload failures for special characters.

> **Cadence:** 1 total versions · 0 majors in last 6 months · 104 days since last update

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Elescan is a market-leading medical app that is free with in-app purchases.
With a 4.2/5 rating from 5 reviews, it delivers strong user satisfaction.

<!-- speakable-start -->
> **Bottom Line:** Elescan succeeds by simplifying HIPAA-compliant document capture for paper-based practices, but its long-term viability depends on integrating with existing EHR systems to avoid being replaced by full-stack clinical software, so the PM should prioritize EHR connectivity over general feature expansion.
<!-- speakable-end -->

**Best for:** Healthcare providers and medical billers who need to digitize, store, and share patient documentation while maintaining HIPAA compliance.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [INVEST] [HIGH IMPACT] Ship EHR integration because it is the primary workflow gap for clinical users → increase retention — *Competitors like Entrupy focus on high-value verification, and clinical users require EHR connectivity to reduce manual data entry.* _(trade-off: deprioritize Push the desktop web console feature updates to Q4 — EHR integration has higher strategic impact.)_
- [ ] [PIVOT] [MEDIUM IMPACT] Audit B2B partnership funnel because medical billers are a key target audience → increase install velocity — *The app description specifically mentions medical billers as a target, but no current B2B distribution mechanism exists.* _(trade-off: deprioritize Pause the social media content calendar — B2B direct sales have higher conversion potential.)_
<!-- /section:pm-actions -->

<!-- section:feature-gaps -->
### Feature Gaps vs Competitors

- EHR platform integration (available in clinical software suites but absent here)
- Offline-first scanning mode (available in AttendStar Scanner but absent here)
<!-- /section:feature-gaps -->

<!-- section:outlook -->
### Outlook: Stable

The market for medical document utilities is consolidating around integrated clinical platforms, leaving standalone scanners exposed to feature-parity threats. Elescan must pivot from a capture utility to a workflow-integration tool to maintain its position against EHR suites that are increasingly adding mobile-capture capabilities.

- 🟢 Physician-led development builds necessary clinical trust, which reduces the friction of adopting new security-focused software in medical settings.
- 🔴 The lack of EHR integration limits the app to a utility tool, which increases churn risk as users seek consolidated clinical workflows.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 4.2/5 |
| Total Reviews | 5 |
| Sentiment | Thrilled (90/100) |
| Confidence | Low |
| Pricing Model | Freemium |
| Platforms | iOS |
| Key Features | 3 analyzed |
| Trend | Mixed |
| Outlook | Stable |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Elescan** (this app) | 4.2/5 | Thrilled | Anescribe, LLC |
| [DomainDig](https://marlvel.ai/intel-report/utilities/domaindig) | 5.0/5 | N/A | Christian Cleberg |
| [QR Master: Creator & Scanner](https://marlvel.ai/intel-report/shopping/qr-master-creator-scanner) | 5.0/5 | N/A | Robust Research And Development Ltd. |
| [VIN Multi-Tool Decoder Pro](https://marlvel.ai/intel-report/business/vin-multi-tool-decoder-pro) | N/A/5 | N/A | Pierre CARRON DE LA CARRIERE |
| [AttendStar Scanner](https://marlvel.ai/intel-report/utilities/attendstar-scanner) | 4.0/5 | Mixed | AttendStar |
| [Entrupy](https://marlvel.ai/intel-report/business/entrupy) | 4.1/5 | N/A | Entrupy |

## Company Profile
- **Developer:** Anescribe, LLC
- **Website:** [https://elescan.com](https://elescan.com)
- **Social:** [Instagram](https://www.instagram.com/anescribe.llc) · [Facebook](https://www.facebook.com/profile.php?id=61584375911503) · [YouTube](https://www.youtube.com/watch) · [LinkedIn](https://www.linkedin.com/company/108340410)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/elescan/id6743489325?uo=4)
- **Dev Site:** [Official Website](https://elescan.com)
- **Sources:** Developer website content, About us / company information, App store metadata, User reviews.

## Related Intel Reports
- [*DomainDig*](https://marlvel.ai/intel-report/utilities/domaindig) (Christian Cleberg) — 5.0/5 Rating | N/A Sentiment
- [*QR Master: Creator & Scanner*](https://marlvel.ai/intel-report/shopping/qr-master-creator-scanner) (Robust Research And Development Ltd.) — 5.0/5 Rating | N/A Sentiment
- [*VIN Multi-Tool Decoder Pro*](https://marlvel.ai/intel-report/business/vin-multi-tool-decoder-pro) (Pierre CARRON DE LA CARRIERE) — N/A Rating | N/A Sentiment
- [*AttendStar Scanner*](https://marlvel.ai/intel-report/utilities/attendstar-scanner) (AttendStar) — 4.0/5 Rating | Mixed Sentiment
- [*Entrupy*](https://marlvel.ai/intel-report/business/entrupy) (Entrupy) — 4.1/5 Rating | N/A Sentiment
- [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment
- [*Ortho Traumapedia*](https://marlvel.ai/intel-report/medical/orthotraumapedia) (HTG, LLC) — 3.5/5 Rating | N/A Sentiment
- [*NYC Employees PPO Plan*](https://marlvel.ai/intel-report/medical/com-uhg-mobile-nyce) (United HealthCare Services, Inc.) — 4.6/5 Rating | N/A Sentiment
- [*DeepScribe*](https://marlvel.ai/intel-report/medical/deepscribe) (DeepScribe) — 4.0/5 Rating | N/A Sentiment
- [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting.
4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.55/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 2
- **Data Sources:** user reviews, developer website, company about page, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 0 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/elescan)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.